LogoCrystal's MCW Coder Hub

H40.051

36 min read

Short Definition

Ocular hypertension, right eye

Long Definition

ICD-10-CM code H40.051 identifies ocular hypertension (OHT) affecting specifically the right eye. Ocular hypertension is defined as consistently elevated intraocular pressure (IOP) greater than 21 mmHg (the statistical upper limit of normal, representing 2 standard deviations above the population mean of approximately 15-16 mmHg) in the absence of glaucomatous optic nerve damage, retinal nerve fiber layer (RNFL) defects, or visual field loss. This condition represents a risk factor and potential precursor to primary open-angle glaucoma (POAG) but is not glaucoma itself by definition. Patients with ocular hypertension are classified as “glaucoma suspects” and require ongoing monitoring to detect conversion to glaucoma.

The diagnosis of ocular hypertension requires multiple IOP measurements on different occasions demonstrating consistently elevated pressure (typically measured on at least 2-3 separate visits), normal-appearing optic nerve head with healthy neuroretinal rim and appropriate cup-to-disc ratio, normal visual field testing showing no defects attributable to glaucoma, open anterior chamber angle on gonioscopy (not angle-closure), and absence of other ocular pathology that could cause elevated IOP or optic nerve damage. The Ocular Hypertension Treatment Study (OHTS), a landmark prospective randomized clinical trial, demonstrated that untreated ocular hypertension converts to primary open-angle glaucoma at a rate of approximately 9.5% over 5 years and 22% over 13 years (roughly 2% per year), while treatment with topical IOP-lowering medications reduces this risk by approximately 50%.

Risk factors for conversion from ocular hypertension to glaucoma include older age, higher baseline IOP, increased vertical and horizontal cup-to-disc ratio, thinner central corneal thickness (CCT less than 555 microns), larger pattern standard deviation on visual field testing despite normal fields, African American race, and positive family history of glaucoma. The decision to treat ocular hypertension with IOP-lowering medications versus observation alone depends on individual risk stratification, with high-risk patients (those with multiple risk factors) more likely to benefit from early treatment. Ocular hypertension itself is typically asymptomatic, as elevated IOP does not cause pain or symptoms unless extremely elevated or associated with angle-closure. Regular monitoring includes IOP measurement, optic nerve evaluation (clinical examination and imaging with OCT or photography), visual field testing, gonioscopy to confirm open angles, and pachymetry to measure central corneal thickness (thinner corneas underestimate true IOP, thicker corneas overestimate).

This code specifically indicates the right eye is affected; if both eyes have ocular hypertension or if the left eye is affected, different codes must be used. Treatment options when indicated include topical prostaglandin analogs, beta-blockers, alpha-agonists, carbonic anhydrase inhibitors, or combination medications, with the goal of reducing IOP by 20-30% from baseline to reduce glaucoma risk. Prognosis is generally good with appropriate monitoring and risk-based management.

Area of Body

Right eye - intraocular pressure regulation system and structures at risk:

Primary Pathophysiology - Right Eye:

Aqueous Humor Dynamics (Elevated IOP):

  • Aqueous production:
    • Ciliary body produces aqueous humor
    • Secreted by ciliary epithelium into posterior chamber
    • Normal production: 2-3 microliters per minute
    • In ocular hypertension: Production typically normal
  • Aqueous outflow (PRIMARY ISSUE IN OCULAR HYPERTENSION):
    • Conventional (trabecular) outflow pathway:
      • Aqueous flows from posterior chamber → through pupil → into anterior chamber → to trabecular meshwork → Schlemm’s canal → collector channels → episcleral veins
      • In ocular hypertension: Increased resistance to outflow through trabecular meshwork
      • Trabecular meshwork dysfunction or structural changes reduce outflow facility
      • Results in elevated IOP despite normal production
    • Unconventional (uveoscleral) outflow:
      • Aqueous passes through ciliary muscle → suprachoroidal space
      • Accounts for ~10-15% of total outflow
      • May be relatively normal in OHT

Intraocular Pressure Elevation:

  • Normal IOP: 10-21 mmHg (mean ~15-16 mmHg, standard deviation ~2.5-3 mmHg)
  • Ocular hypertension: IOP >21 mmHg (>2 standard deviations above mean)
  • IOP in OHT typically: 22-32 mmHg (mild to moderate elevation)
  • IOP >40 mmHg: Requires immediate treatment (high risk)
  • Diurnal variation: IOP fluctuates throughout day; peak often morning

Structures at Risk (Currently Healthy in OHT):

Optic Nerve Head:

  • Currently: Normal-appearing in ocular hypertension (by definition)
  • Neuroretinal rim: Healthy, pink, well-perfused tissue
  • Cup-to-disc ratio (CDR): Within normal limits (typically <0.5-0.6)
  • ISNT rule: Intact (Inferior rim thickest, Superior, Nasal, Temporal thinnest)
  • At risk: Chronic elevated IOP can damage optic nerve over time, leading to glaucoma
  • Mechanism of damage: Mechanical compression of axons at lamina cribrosa, vascular insufficiency

Retinal Nerve Fiber Layer (RNFL):

  • Currently: Normal thickness in ocular hypertension
  • Function: Contains 1.2 million retinal ganglion cell axons traveling to optic nerve
  • At risk: RNFL thinning is early sign of glaucomatous damage
  • Monitored by: OCT (optical coherence tomography) showing thickness measurements

Retinal Ganglion Cells:

  • Currently: Healthy and functioning normally in OHT
  • Function: Transmit visual information from retina to brain via optic nerve
  • At risk: Ganglion cell death occurs in glaucoma, irreversible vision loss
  • Located: Primarily in macula and peripapillary region

Visual Field:

  • Currently: Normal in ocular hypertension (no defects)
  • At risk: Glaucomatous visual field loss typically starts peripherally
  • Mechanism: Damage to ganglion cells causes corresponding visual field defects
  • Pattern: Arcuate scotomas, nasal step, generalized depression, eventual tunnel vision

Anterior Chamber Angle:

  • Must be OPEN in ocular hypertension (by definition)
  • Angle structures visible on gonioscopy
  • Trabecular meshwork accessible for aqueous outflow
  • If angle closed: Different diagnosis (angle-closure glaucoma, not OHT)

Cornea:

  • Central corneal thickness (CCT):
    • Normal average: ~545-555 microns
    • Thin cornea (<555 microns): Associated with underestimation of true IOP, increased glaucoma risk
    • Thick cornea (>588 microns): Overestimates IOP, lower glaucoma risk
    • CCT measurement (pachymetry) essential for risk stratification
    • OHTS identified CCT as major risk factor: Thin CCT = 3x higher glaucoma risk

Vascular Supply:

  • Optic nerve head perfusion:
    • Blood flow from posterior ciliary arteries
    • Perfusion pressure = Blood pressure - IOP
    • Elevated IOP reduces perfusion pressure
    • May contribute to ischemic optic neuropathy mechanism
  • At risk: Vascular insufficiency contributing to glaucoma development

No Structural Damage Yet in OHT:

  • By definition, ocular hypertension has NO optic nerve damage
  • NO RNFL thinning
  • NO visual field defects
  • Condition is “pre-glaucomatous” - risk factor, not disease

Conversion to Glaucoma:
When OHT converts to glaucoma, damage occurs:

  • Optic nerve head cupping increases (larger cup-to-disc ratio)
  • Neuroretinal rim becomes thinner, notched, or hemorrhages appear
  • RNFL thins (detected on OCT)
  • Visual field defects develop
  • Retinal ganglion cells die (irreversible)

Clinical Presentation and Diagnosis

Patient Presentation:

Typical Presentation:

  • ASYMPTOMATIC (most common)
    • Ocular hypertension does NOT cause symptoms
    • No pain (unlike acute angle-closure glaucoma)
    • No vision loss (vision loss occurs in glaucoma, not OHT)
    • No redness, no halos, no discomfort
  • Discovered incidentally:
    • Routine eye examination
    • Screening tonometry
    • Insurance physical exam
    • DMV vision screening
    • Pre-operative evaluation

Patient History:

  • Usually no eye complaints
  • May have family history of glaucoma (risk factor)
  • May have systemic conditions:
    • Hypertension
    • Diabetes
    • Cardiovascular disease
    • Migraine
    • Sleep apnea
  • Medication history:
    • Corticosteroids (systemic, topical, inhaled) can cause IOP elevation
    • Anticholinergics
  • Previous eye history:
    • Eye trauma
    • Eye surgery
    • Uveitis

Physical/Ophthalmologic Examination:

Visual Acuity:

  • Normal (20/20 or baseline for patient)
  • No vision loss in uncomplicated ocular hypertension

Intraocular Pressure (IOP) - HALLMARK FINDING:

  • Measurement methods:
    • Goldmann applanation tonometry (GAT): Gold standard
    • Tonopen (handheld)
    • Pneumatonometry
    • Non-contact tonometry (air puff)
    • Rebound tonometry (iCare)
  • Definition of ocular hypertension:
    • IOP >21 mmHg on multiple occasions (at least 2-3 separate visits)
    • Single elevated reading insufficient for diagnosis
    • Must rule out measurement error, white coat effect
  • Typical IOP in OHT: 22-32 mmHg
  • Diurnal IOP variation:
    • IOP fluctuates throughout day (peak often 6-8 AM)
    • Diurnal curve may be obtained (IOP measured multiple times throughout day)

    • 5 mmHg fluctuation may increase risk

Slit Lamp Examination:

  • Anterior segment: Normal
  • Cornea: Clear, no edema
  • Anterior chamber: Deep and quiet (no cells/flare)
  • Iris: Normal, no neovascularization
  • Lens: May have cataract (age-related, unrelated to OHT)

Gonioscopy - ESSENTIAL:

  • Angle must be OPEN for diagnosis of ocular hypertension
  • Visualize angle structures (Schwalbe’s line, trabecular meshwork, scleral spur, ciliary body band)
  • Shaffer grading: Grade 3-4 (wide open angle)
  • Spaeth classification: Document angle configuration
  • If angle narrow or closed: Not OHT, consider angle-closure mechanism
  • Pigment dispersion, pseudoexfoliation noted if present (secondary causes of IOP elevation)

Optic Nerve Examination - MUST BE NORMAL:

  • Direct ophthalmoscopy or slit lamp biomicroscopy with lens
  • Dilated examination essential
  • Must document:
    • Cup-to-disc ratio (CDR):
      • Vertical CDR typically <0.5-0.6 in OHT
      • Horizontal CDR
      • CDR asymmetry between eyes (>0.2 difference concerning)
    • Neuroretinal rim: Healthy, pink, intact ISNT rule
    • Disc hemorrhages: Absent (presence suggests glaucoma)
    • RNFL defects: Absent (presence suggests glaucoma)
    • Peripapillary atrophy: Minimal or absent
    • Disc size: Large discs have larger physiologic cups
  • Optic nerve photography: Baseline documentation for future comparison

Visual Field Testing - MUST BE NORMAL:

  • Automated perimetry: Humphrey Visual Field, Octopus, etc.
  • Test protocols:
    • 24-2 or 30-2 SITA Standard or SITA Fast
    • Central 24 or 30 degrees of vision
  • In ocular hypertension: Normal visual fields (by definition)
    • Mean deviation (MD): Within normal limits
    • Pattern standard deviation (PSD): Normal or minimally elevated
    • Glaucoma Hemifield Test (GHT): Within normal limits
  • Baseline essential: To detect future changes
  • Frequency: Annually or more often if high risk

Optical Coherence Tomography (OCT) - IMPORTANT:

  • RNFL thickness:
    • Measures retinal nerve fiber layer around optic nerve
    • In OHT: Normal thickness (typically average >85-90 microns)
    • Establishes baseline for future comparison
  • Ganglion Cell Complex (GCC):
    • Measures macular ganglion cell layer
    • Detects early glaucomatous changes
  • Optic nerve head analysis:
    • Rim area, disc area, cup volume
    • Quantifies optic nerve parameters

Pachymetry - ESSENTIAL FOR RISK STRATIFICATION:

  • Central corneal thickness (CCT) measurement
  • Methods:
    • Ultrasonic pachymetry
    • Optical pachymetry (on OCT or Pentacam)
  • Normal CCT: ~545-555 microns (varies by race/ethnicity)
  • OHTS findings:
    • Thin CCT (<555 microns): 3x higher risk of glaucoma development
    • Thick CCT (>588 microns): Lower risk of glaucoma
  • Thin cornea: Applanation tonometry underestimates true IOP
  • Thick cornea: Applanation tonometry overestimates IOP
  • CCT correction formulas: Exist but not universally used

Additional Testing (Risk Stratification):

  • Baseline demographics:
    • Age (older = higher risk)
    • Race (African American = higher risk)
    • Family history of glaucoma
  • Systemic evaluation:
    • Blood pressure
    • Cardiovascular health
    • Diabetes status

Diagnostic Criteria for Ocular Hypertension:

  1. IOP >21 mmHg on multiple occasions (at least 2-3 visits)
  2. Normal optic nerve appearance (healthy rim, appropriate CDR)
  3. Normal visual fields (no glaucomatous defects)
  4. Open anterior chamber angle on gonioscopy
  5. No other ocular disease causing elevated IOP or optic nerve damage

Differential Diagnosis:

Must Rule Out:

  • Primary open-angle glaucoma (POAG):
    • Has optic nerve damage, RNFL loss, or visual field defects
    • Different code: H40.11— series
  • Angle-closure glaucoma:
    • Narrow or closed angle on gonioscopy
    • Different code: H40.20— series
  • Normal-tension glaucoma:
    • Glaucomatous damage with IOP ≤21 mmHg
    • Different code: H40.12— series
  • Secondary glaucoma:
    • Elevated IOP from identifiable cause (trauma, uveitis, steroids, pseudoexfoliation, pigment dispersion)
    • Different codes: H40.3—, H40.4—, H40.5—
  • Steroid-induced glaucoma:
    • History of corticosteroid use
    • Code: H40.6—
  • Measurement error:
    • Improper tonometry technique
    • White coat hypertension
    • Confirm with repeated measurements

Conditions That May Coexist:

  • Glaucoma suspect with other features:
    • Large cup-to-disc ratio but normal fields (physiologic cupping)
    • Asymmetric CDR without damage
    • Suspicious-appearing disc without functional loss

Includes

This Code Encompasses:

  • Ocular hypertension affecting right eye only
  • Consistently elevated intraocular pressure (IOP >21 mmHg) right eye
  • Glaucoma suspect status based on elevated IOP, right eye
  • Pre-glaucomatous condition, right eye
  • High intraocular pressure without optic nerve damage, right eye
  • Elevated eye pressure requiring monitoring, right eye

Clinical Scenarios Included:

  • Patient with IOP 24-26 mmHg right eye, normal optic nerve, normal visual fields, open angles
  • Patient identified on routine screening with elevated IOP right eye
  • Patient being monitored for conversion to glaucoma, right eye
  • Patient on observation protocol for ocular hypertension, right eye
  • Patient being treated with IOP-lowering medications for ocular hypertension, right eye (after risk assessment)

Risk Levels:

  • Low-risk ocular hypertension (few risk factors, IOP 22-24 mmHg, thick cornea)
  • Moderate-risk ocular hypertension (some risk factors, IOP 25-28 mmHg)
  • High-risk ocular hypertension (multiple risk factors: thin CCT, high IOP >28-30 mmHg, large CDR, older age, African American, family history)

Treatment Status:

  • Untreated ocular hypertension (observation only)
  • Treated ocular hypertension (on IOP-lowering medications)

Excludes

Excludes1 (Cannot Code Together - Mutually Exclusive):

At H40 Category Level:

  • H44.51- - Absolute glaucoma (end-stage glaucoma with no light perception)
    • Completely different condition - severe end-stage disease
  • Q15.0 - Congenital glaucoma (infantile glaucoma, present at birth)
    • Developmental condition, not acquired ocular hypertension
  • P15.3 - Traumatic glaucoma due to birth injury
    • Birth-related trauma, not ocular hypertension

Within H40.05 (Ocular Hypertension) - Different Laterality:

  • H40.052 - Ocular hypertension, LEFT eye (different eye)
  • H40.053 - Ocular hypertension, BILATERAL (both eyes)
  • H40.059 - Ocular hypertension, UNSPECIFIED eye (laterality not documented)

Cannot Code If Glaucoma Present:
If patient has developed glaucoma (optic nerve damage, RNFL loss, or visual field defects), can NO LONGER code as ocular hypertension. Must use glaucoma codes:

  • H40.11— - Primary open-angle glaucoma (if conversion occurred)
  • H40.12— - Low-tension glaucoma (if IOP normal but damage present)
  • H40.13— - Pigmentary glaucoma (if pigment dispersion caused glaucoma)
  • H40.14— - Capsular glaucoma with pseudoexfoliation (if pseudoexfoliation present)
  • H40.15— - Residual stage of open-angle glaucoma

Different from Secondary Causes of Elevated IOP:
If identifiable secondary cause present, use specific secondary glaucoma codes, not H40.051:

  • H40.3— - Glaucoma secondary to eye trauma
  • H40.4— - Glaucoma secondary to eye inflammation
  • H40.5— - Glaucoma secondary to other eye disorders
  • H40.6— - Glaucoma secondary to drugs (steroid-induced)
  • H40.81— - Glaucoma with increased episcleral venous pressure
  • H40.82— - Hypersecretion glaucoma (aqueous misdirection)
  • H40.83— - Aqueous misdirection

Not the Same as Angle-Closure:

  • H40.20— - Unspecified primary angle-closure glaucoma
  • H40.21— - Acute angle-closure glaucoma
  • H40.22— - Chronic angle-closure glaucoma
  • Ocular hypertension (H40.051) requires OPEN angle; if angle narrow/closed, different diagnosis

Coding Rule:

  • Ocular hypertension = elevated IOP WITHOUT glaucomatous damage
  • Once glaucoma develops (damage present), change from H40.051 to appropriate glaucoma code
  • Cannot code both OHT and glaucoma for same eye

HCC Status

HCC Mapping: Does NOT map to an HCC Category

ICD-10 code H40.051 (ocular hypertension, right eye) does NOT map to a Hierarchical Condition Category (HCC) under the CMS-HCC risk adjustment model.

Why Not an HCC:

  • Ocular hypertension is risk factor/pre-glaucomatous condition, not established disease
  • Does not predict high annual healthcare costs
  • Treatment is preventive (reducing glaucoma risk), not managing established disease
  • Monitoring and treatment relatively low-cost (eye drops, office visits, testing)
  • Not among the HCC categories in CMS models
  • Even established glaucoma typically does not map to HCC

HCC Model Focus:

  • Chronic diseases with high management costs
  • Conditions requiring frequent interventions
  • Major organ system diseases
  • Predictors of high resource utilization

Ocular Hypertension Characteristics (Non-HCC):

  • Pre-disease state (risk factor)
  • Treatment preventive, not curative
  • Low annual healthcare costs
  • Medication costs modest (topical eye drops)
  • Monitoring involves routine office visits and testing
  • Does not generate high resource utilization

Glaucoma Also Generally Not HCC:

  • Even if OHT converts to glaucoma, glaucoma codes (H40.11—, etc.) typically do NOT map to HCCs
  • Vision loss from advanced glaucoma not typically HCC
  • Occasional exceptions in specific model versions for severe vision impairment

Clinical Implications:

  • Document H40.051 for clinical accuracy and care coordination
  • Important for patient management and glaucoma prevention
  • Not relevant for risk adjustment or HCC coding
  • Does not impact Medicare Advantage capitated payments

wRVU Status

Not Applicable - ICD-10 diagnosis codes do not have wRVU (work Relative Value Units) values.

wRVUs apply only to CPT procedure codes. ICD-10 codes document the diagnosis.

Related CPT Codes with wRVUs for Evaluation and Management of H40.051:

Ophthalmology Examination:

  • 92002 - Intermediate, new patient: 0.92 wRVU
  • 92004 - Comprehensive, new patient: 1.50 wRVU
  • 92012 - Intermediate, established patient: 0.66 wRVU
  • 92014 - Comprehensive, established patient: 1.09 wRVU

Tonometry (Included in Examination):

  • Tonometry typically included in comprehensive/intermediate exam
  • 92100 - Serial tonometry (multiple measurements over time): 0.14 wRVU

Gonioscopy:

  • 92020 - Gonioscopy: 0.64 wRVU
    • Essential for diagnosing OHT (confirm open angle)

Optic Nerve Imaging:

  • 92133 - OCT optic nerve head with interpretation: 0.52 wRVU
  • 92250 - Fundus photography with interpretation: 0.61 wRVU

Visual Field Testing:

  • 92081 - Visual field examination, limited: 0.22 wRVU
  • 92082 - Intermediate: 0.37 wRVU
  • 92083 - Extended (Humphrey 24-2, 30-2): 0.53 wRVU

Pachymetry:

  • 76514 - Ophthalmic ultrasound, corneal pachymetry, unilateral or bilateral: 0.25 wRVU
    • Essential for risk stratification in OHT

Primary Care:

  • 99201-99205 - New patient office visit: 0.92 to 3.17 wRVU
  • 99211-99215 - Established patient office visit: 0.18 to 1.92 wRVU

Assistant Surgeon Status

Not Applicable - ICD-10 diagnosis codes do not have assistant surgeon payment policies.

H40.051 is a diagnosis code for ocular hypertension, which does not require surgery. Management is medical (eye drops) or observation. No surgical procedures indicated for uncomplicated ocular hypertension.

If Glaucoma Develops and Surgery Needed:

  • Trabeculectomy, tube shunt, MIGS procedures
  • Assistant surgeon policies would apply to surgical CPT codes
  • But those procedures for glaucoma, not OHT

Common Modifiers

Not Applicable for Diagnosis Code

ICD-10 diagnosis codes do not use CPT modifiers. Modifiers are appended to CPT procedure codes.

Laterality Built Into Code:

  • H40.051 = RIGHT eye (laterality specified in code)
  • H40.052 = LEFT eye
  • H40.053 = BILATERAL
  • H40.059 = Unspecified eye
  • No RT/LT modifiers needed on diagnosis code

When Billing CPT Procedures:
CPT codes may use modifiers:

  • -RT - Right side (use on procedure codes when examining right eye)
  • -LT - Left side (for left eye)
  • -26 - Professional component (for imaging interpretation)
  • -TC - Technical component (for imaging equipment/performance)

Common Associated Codes

Related ICD-10 Diagnosis Codes:

ICD-10 CodeDescriptionRelationship to H40.051
H40.052Ocular hypertension, left eyeContralateral eye
H40.053Ocular hypertension, bilateralBoth eyes affected
H40.059Ocular hypertension, unspecified eyeLaterality not documented
H40.001-003-009Preglaucoma, unspecifiedLess specific glaucoma suspect
H40.011-013-019Open angle with borderline findings, low riskGlaucoma suspect, low risk
H40.021-023-029Open angle with borderline findings, high riskGlaucoma suspect, high risk (more ominous than simple OHT)
H40.1111-113-119Primary open-angle glaucoma (mild)IF OHT converts to glaucoma (can no longer code H40.051)
H40.121-123-129Low-tension glaucomaGlaucoma with normal IOP
H40.131-133-139Pigmentary glaucomaSecondary glaucoma from pigment dispersion
H40.141-143-149Capsular glaucoma with pseudoexfoliationSecondary glaucoma from pseudoexfoliation
H40.211-213-219Acute angle-closure glaucomaDifferent mechanism (closed angle)
H40.221-223-229Chronic angle-closure glaucomaDifferent mechanism
H40.61X1-3-4-9Glaucoma secondary to drugsSteroid-induced glaucoma
I10Essential hypertensionSystemic hypertension often coexists
E11.9Type 2 diabetes mellitusDiabetes risk factor for glaucoma
Z79.4Long-term use of insulinIf diabetic on insulin
Z79.899Long-term use of other medicationsIf on IOP-lowering medications
Z13.5Encounter for screening for eye disordersVision screening visits
Z82.11Family history of glaucomaImportant risk factor

Common Associated CPT Procedure Codes:

CPT CodeDescriptionWhen Used with H40.051
92002Ophthalmological examination, intermediate, new patientInitial evaluation
92004Ophthalmological examination, comprehensive, new patientComprehensive initial assessment with dilation
92012Ophthalmological examination, intermediate, establishedFollow-up visits (typically annual or more frequent if high risk)
92014Ophthalmological examination, comprehensive, establishedAnnual comprehensive with dilation
92020GonioscopyEssential to confirm open angle (diagnose OHT)
92100Serial tonometryMultiple IOP measurements on same day or over time
92133OCT optic nerve head with interpretationBaseline and serial RNFL thickness monitoring
92134OCT retinaMacular ganglion cell complex assessment
92250Fundus photography with interpretationDocument optic nerve appearance
92081Visual field examination, limitedScreening visual fields
92083Visual field examination, extendedHumphrey 24-2 or 30-2, baseline and serial monitoring
76514Ophthalmic ultrasound, corneal pachymetryCCT measurement for risk stratification (ESSENTIAL)
99201-99205Office visit, new patientPrimary care or consultation
99211-99215Office visit, established patientFollow-up management
99386-99387Preventive medicine visit, established patient age 40+Well visits where OHT discovered

Medications (HCPCS J-Codes Not Typically Used for Topical Eye Drops):
Topical glaucoma medications (if treatment initiated):

  • Prostaglandin analogs: Latanoprost (Xalatan), Travoprost (Travatan), Bimatoprost (Lumigan), Tafluprost (Zioptan)
  • Beta-blockers: Timolol, Betaxolol, Levobunolol, Carteolol
  • Alpha-agonists: Brimonidine (Alphagan), Apraclonidine
  • Carbonic anhydrase inhibitors: Dorzolamide (Trusopt), Brinzolamide (Azopt), Acetazolamide (oral)
  • Combination drops: Cosopt (dorzolamide/timolol), Combigan (brimonidine/timolol), Simbrinza (brinzolamide/brimonidine)
  • Rho kinase inhibitors: Netarsudil (Rhopressa)

(Prescriptions, not injectable; no J-codes typically)

Code Tree/Hierarchy

ICD-10-CM Chapter: 7 - Diseases of the Eye and Adnexa (H00-H59)

Block: H40-H42 - Glaucoma

Category: H40 - Glaucoma

Structure:

H40 - Glaucoma
│
├── H40.0 - Glaucoma suspect ◄ Current Subcategory
│   │
│   ├── H40.00 - Preglaucoma, unspecified
│   │   ├── H40.001 - Preglaucoma, unspecified, right eye
│   │   ├── H40.002 - Preglaucoma, unspecified, left eye
│   │   ├── H40.003 - Preglaucoma, unspecified, bilateral
│   │   └── H40.009 - Preglaucoma, unspecified, unspecified eye
│   │
│   ├── H40.01 - Open angle with borderline findings, low risk
│   │   ├── H40.011 - Low risk, right eye
│   │   ├── H40.012 - Low risk, left eye
│   │   ├── H40.013 - Low risk, bilateral
│   │   └── H40.019 - Low risk, unspecified eye
│   │
│   ├── H40.02 - Open angle with borderline findings, high risk
│   │   ├── H40.021 - High risk, right eye
│   │   ├── H40.022 - High risk, left eye
│   │   ├── H40.023 - High risk, bilateral
│   │   └── H40.029 - High risk, unspecified eye
│   │
│   ├── H40.03 - Anatomical narrow angle
│   │   ├── H40.031 - Anatomical narrow angle, right eye
│   │   ├── H40.032 - Anatomical narrow angle, left eye
│   │   ├── H40.033 - Anatomical narrow angle, bilateral
│   │   └── H40.039 - Anatomical narrow angle, unspecified eye
│   │
│   └── H40.05 - Ocular hypertension ◄ Current Group
│       ├── H40.051 - Ocular hypertension, right eye ◄ CURRENT CODE
│       ├── H40.052 - Ocular hypertension, left eye
│       ├── H40.053 - Ocular hypertension, bilateral
│       └── H40.059 - Ocular hypertension, unspecified eye
│
├── H40.1 - Open-angle glaucoma
│   ├── H40.10 - Unspecified open-angle glaucoma (stage unspecified)
│   ├── H40.11 - Primary open-angle glaucoma
│   ├── H40.12 - Low-tension glaucoma
│   ├── H40.13 - Pigmentary glaucoma
│   ├── H40.14 - Capsular glaucoma with pseudoexfoliation
│   └── H40.15 - Residual stage of open-angle glaucoma
│
├── H40.2 - Primary angle-closure glaucoma
├── H40.3 - Glaucoma secondary to eye trauma
├── H40.4 - Glaucoma secondary to eye inflammation
├── H40.5 - Glaucoma secondary to other eye disorders
├── H40.6 - Glaucoma secondary to drugs
├── H40.8 - Other glaucoma
└── H40.9 - Unspecified glaucoma

Glaucoma Suspect Subcategories (H40.0-):

CodeDescriptionKey Features
H40.00-Preglaucoma, unspecifiedNon-specific glaucoma suspect
H40.01-Open angle, borderline, LOW riskSuspicious features, low risk of progression
H40.02-Open angle, borderline, HIGH riskSuspicious features, HIGH risk of progression
H40.03-Anatomical narrow angleNarrow but open angle, angle-closure risk
H40.05-Ocular hypertensionElevated IOP, normal nerve/fields ◄ CURRENT

Code Selection Decision Tree:

Elevated IOP Detected in Right Eye?
│
├── Is there GLAUCOMATOUS DAMAGE present?
│   │
│   ├── YES - Damage present (optic nerve changes, RNFL loss, visual field defects)
│   │   └── Code as GLAUCOMA (H40.1--)
│   │       ├── Primary open-angle glaucoma → H40.111 (mild), H40.112 (moderate), H40.113 (severe)
│   │       ├── Low-tension glaucoma → H40.121-123
│   │       ├── Pigmentary glaucoma → H40.131-133
│   │       └── Other types based on findings
│   │
│   └── NO - No damage present
│       │
│       ├── Is IOP consistently elevated (>21 mmHg)?
│       │   │
│       │   ├── YES - IOP >21 mmHg
│       │   │   │
│       │   │   ├── Is angle OPEN on gonioscopy?
│       │   │   │   │
│       │   │   │   ├── YES - Open angle
│       │   │   │   │   └── H40.051 - Ocular hypertension, right eye ◄ CURRENT CODE
│       │   │   │   │
│       │   │   │   └── NO - Angle narrow/closed
│       │   │   │       └── H40.03- (narrow angle) or H40.2-- (angle-closure)
│       │   │   │
│       │   │   └── Is there secondary cause (trauma, inflammation, steroids)?
│       │   │       └── YES - Use H40.3--, H40.4--, H40.6-- (secondary glaucoma codes)
│       │   │
│       │   └── NO - IOP normal (≤21 mmHg)
│       │       └── But suspicious optic nerve or other findings?
│       │           ├── YES → H40.01- (low risk) or H40.02- (high risk) based on risk factors
│       │           └── NO → Normal, no glaucoma suspect code needed
│       │
│       └── Which EYE affected?
│           ├── Right eye only → H40.051 ◄ CURRENT CODE
│           ├── Left eye only → H40.052
│           ├── Both eyes → H40.053
│           └── Unspecified → H40.059

Progression Path:

Normal Eye (IOP ≤21 mmHg, normal nerve)
│
↓
Ocular Hypertension (H40.051)
│   - IOP >21 mmHg
│   - Normal optic nerve
│   - Normal visual fields
│   - Open angle
│   - ~2% per year conversion to glaucoma
│
↓ (If glaucomatous damage develops)
│
Primary Open-Angle Glaucoma (H40.11-)
│   - IOP usually elevated (but may be normal)
│   - Optic nerve damage
│   - RNFL thinning
│   - Visual field defects
│   - Irreversible vision loss
│
↓ (Stages of glaucoma severity)
│
├── Mild glaucoma (H40.111-) - Early damage
├── Moderate glaucoma (H40.112-) - Moderate damage
├── Severe glaucoma (H40.113-) - Advanced damage
└── Indeterminate stage (H40.119-) - Severity not specified

Coding Examples

Example 1: New Diagnosis of Ocular Hypertension - Right Eye

Clinical Scenario:
62-year-old African American female presents for routine eye examination.

History:

  • No eye complaints
  • Family history: Mother had glaucoma
  • Medical history: Hypertension (controlled), no diabetes
  • No prior glaucoma treatment

Examination:

  • Visual acuity: 20/20 both eyes
  • IOP:
    • Right eye: 26 mmHg
    • Left eye: 18 mmHg
  • Gonioscopy: Open angles bilaterally (Shaffer grade 3-4)
  • Dilated fundus examination:
    • Right eye: Optic nerve healthy, C/D ratio 0.4, neuroretinal rim intact, no hemorrhages, no RNFL defects
    • Left eye: Optic nerve normal, C/D 0.3
  • OCT RNFL: Right eye average 98 microns (normal), left eye 102 microns (normal)
  • Visual fields (Humphrey 24-2): Normal both eyes - no defects
  • Pachymetry:
    • Right eye: 535 microns (thin - risk factor)
    • Left eye: 540 microns

Assessment:

  • Ocular hypertension, right eye (elevated IOP without glaucomatous damage)
  • HIGH RISK for glaucoma conversion based on:
    • Elevated IOP (26 mmHg)
    • Thin central corneal thickness (535 microns - below 555 threshold)
    • African American race
    • Positive family history of glaucoma
    • Age over 60

Plan:

  • Discussed OHTS findings and 50% risk reduction with treatment
  • Given high-risk profile, recommend treatment initiation
  • Start prostaglandin analog (latanoprost) right eye nightly
  • Target IOP <21 mmHg (20-30% reduction from baseline)
  • Return in 4-6 weeks to assess IOP response
  • Repeat visual fields and OCT annually
  • Monitor for conversion to glaucoma

ICD-10-CM Coding:

  • H40.051 - Ocular hypertension, right eye (PRIMARY)
  • Z82.11 - Family history of glaucoma (risk factor)
  • I10 - Essential hypertension (comorbidity)

CPT Coding:

  • 92004 - Comprehensive ophthalmological examination, new patient (OR 92014 if established)
  • 92020 - Gonioscopy (bilateral, but may code once)
  • 92083 - Visual field examination, extended (Humphrey 24-2)
  • 92133 - OCT optic nerve head with interpretation
  • 76514 - Corneal pachymetry

Rationale:
H40.051 appropriate as IOP elevated right eye without glaucomatous damage. Comprehensive workup confirms open angle, normal optic nerve, normal visual fields. CCT measurement essential for risk stratification. High-risk patient appropriate for treatment initiation.

Example 2: Ocular Hypertension - Observation Protocol (Low Risk)

Clinical Scenario:
45-year-old white male with incidental finding of elevated IOP.

History:

  • Discovered at DMV vision screening, referred to ophthalmology
  • No symptoms
  • No family history of glaucoma
  • Excellent general health, no medications

Examination:

  • Visual acuity: 20/20 both eyes
  • IOP:
    • Right eye: 24 mmHg
    • Left eye: 22 mmHg
  • Gonioscopy: Wide open angles
  • Dilated fundus exam: Normal optic nerves bilaterally, C/D 0.3 both eyes
  • Visual fields: Normal
  • OCT RNFL: Normal thickness
  • Pachymetry:
    • Right eye: 595 microns (thick - protective factor)
    • Left eye: 600 microns (thick)

Assessment:

  • Ocular hypertension, bilateral (both eyes mildly elevated)
  • LOW RISK for glaucoma:
    • Modest IOP elevation (24 mmHg)
    • Thick corneas (595-600 microns) - IOP likely overestimated
    • Young age (45)
    • Small cup-to-disc ratio (0.3)
    • No family history
    • Caucasian
  • OHTS risk calculator: <5% 5-year glaucoma risk

Plan:

  • Observation without treatment (low-risk patient)
  • Patient counseled on low glaucoma risk
  • Monitor IOP, optic nerves, visual fields annually
  • Re-assess risk if circumstances change
  • Warned about symptoms requiring urgent evaluation (though unlikely)

ICD-10-CM Coding:

  • H40.053 - Ocular hypertension, bilateral (both eyes affected)
  • H40.011 - Open angle with borderline findings, low risk, right eye (alternative if emphasizing low-risk status)

CPT Coding:

  • 92004 - Comprehensive examination
  • 92020 - Gonioscopy
  • 92083 - Visual fields
  • 92133 - OCT
  • 76514 - Pachymetry

Rationale:
H40.053 (bilateral OHT) appropriate. Patient has elevated IOP bilaterally without damage. Thick corneas suggest true IOP likely lower than measured. Low-risk profile makes observation reasonable per OHTS. No treatment initiated. Annual monitoring planned.

Example 3: Ocular Hypertension Converts to Glaucoma - CODE CHANGE

Clinical Scenario:
68-year-old patient with known ocular hypertension right eye, followed for 5 years, returns for annual examination.

Prior History:

  • H40.051 - Ocular hypertension, right eye (diagnosed 5 years ago)
  • IOP typically 24-26 mmHg right eye on treatment with timolol
  • Previous exams: Normal optic nerve, normal visual fields
  • Moderate risk, opted for treatment

Current Examination:

  • Visual acuity: 20/20 right eye, 20/20 left eye
  • IOP: Right eye 18 mmHg (well-controlled on timolol), Left eye 16 mmHg
  • Dilated fundus exam - Right eye:
    • Optic nerve shows PROGRESSION:
      • C/D ratio now 0.7 (was 0.5 five years ago)
      • Inferior neuroretinal rim thinning
      • Disc hemorrhage at 7 o’clock position (Drance hemorrhage - concerning)
  • OCT RNFL - Right eye:
    • Average thickness decreased to 72 microns (was 88 microns five years ago)
    • Inferior quadrant thinning to 65 microns (red zone)
    • Significant progression from baseline
  • Visual field - Right eye:
    • NEW superior arcuate scotoma (corresponding to inferior nerve fiber loss)
    • Pattern deviation shows defect
    • GHT: Outside normal limits
  • Left eye: Stable, normal

Assessment:

  • Primary open-angle glaucoma, mild stage, right eye (CONVERTED from ocular hypertension)
  • Evidence of glaucomatous progression:
    • Optic nerve cupping increased
    • Disc hemorrhage (sign of active damage)
    • RNFL thinning on OCT
    • New visual field defect
  • Can NO LONGER code as ocular hypertension - now glaucoma

Plan:

  • Diagnosis changed from OHT to POAG
  • Increase treatment: Add prostaglandin analog to regimen
  • Target IOP <15 mmHg (lower target for established glaucoma)
  • More frequent monitoring: Every 3-4 months initially
  • Repeat VF and OCT in 6 months to assess stability
  • Consider laser trabeculoplasty if progression continues

ICD-10-CM Coding - CHANGED:

  • H40.1111 - Primary open-angle glaucoma, right eye, mild stage (NEW - CHANGED from H40.051)
    • Can NO LONGER use H40.051 once glaucoma developed
  • Z79.899 - Long-term use of other medications (glaucoma drops)

CPT Coding:

  • 92014 - Comprehensive examination
  • 92083 - Visual fields
  • 92133 - OCT

Rationale:
Patient CONVERTED from ocular hypertension to glaucoma. Evidence of glaucomatous damage now present (optic nerve changes, RNFL loss, visual field defect). Must change code from H40.051 (OHT) to H40.1111 (POAG, mild stage). This represents disease progression despite treatment. More aggressive management required.

Example 4: Bilateral Ocular Hypertension (Wrong Code Example)

Clinical Scenario:
Patient with elevated IOP both eyes.

Examination:

  • IOP: 25 mmHg right eye, 24 mmHg left eye
  • Both eyes: Normal optic nerves, normal visual fields, open angles

Incorrect Coding:

  • H40.051 - Ocular hypertension, right eye (INCOMPLETE - both eyes affected)
  • H40.052 - Ocular hypertension, left eye (WRONG - don’t code separately)

Correct Coding:

  • H40.053 - Ocular hypertension, BILATERAL

Rationale:
When both eyes have same condition, use bilateral code, not separate right and left codes.

Example 5: Secondary Glaucoma from Steroids (Not Ocular Hypertension)

Clinical Scenario:
55-year-old with rheumatoid arthritis on prednisone 20mg daily for 3 months presents with elevated IOP.

History:

  • Started high-dose oral prednisone 3 months ago
  • No prior eye problems
  • No prior elevated IOP

Examination:

  • IOP: Right eye 32 mmHg, left eye 30 mmHg (significantly elevated)
  • Optic nerves: Normal currently
  • Visual fields: Normal currently
  • Open angles

Assessment:

  • Steroid-induced ocular hypertension / steroid-response
  • Secondary cause identified (prednisone)
  • Not primary ocular hypertension

Incorrect Coding:

  • H40.051 - Ocular hypertension, right eye (WRONG - secondary cause present)

Correct Coding:

  • H40.63X1 - Glaucoma secondary to drugs, right eye, mild stage (if no damage yet, some coders use this)
  • OR T38.0X5A - Adverse effect of glucocorticoids, initial encounter (if emphasizing drug adverse effect)
  • May also code: M06.9 - Rheumatoid arthritis, unspecified (underlying condition)

Plan:

  • Coordinate with rheumatology to taper prednisone if possible
  • Consider steroid-sparing immunosuppressant
  • Start IOP-lowering medication
  • Close monitoring for glaucoma development

Rationale:
H40.051 (ocular hypertension) is for PRIMARY elevated IOP without identifiable cause. When secondary cause present (steroids), use appropriate secondary glaucoma code (H40.6—) or adverse drug effect code. Treatment includes addressing underlying cause (taper steroids) in addition to IOP-lowering therapy.

Example 6: Measurement Error - Not True Ocular Hypertension

Clinical Scenario:
Patient comes to ophthalmology after primary care doctor measured IOP 28 mmHg right eye with Tonopen.

Repeat Examination:

  • Goldmann applanation tonometry: Right eye 18 mmHg, Left eye 17 mmHg (NORMAL)
  • All examination findings normal

Assessment:

  • Normal IOP - prior measurement likely error
  • Thick corneas noted (may have caused Tonopen overestimation)
  • NOT ocular hypertension

Do NOT Code:

  • H40.051 - Inappropriate, patient does not have OHT

Correct Coding:

  • Z01.00 - Encounter for examination of eyes and vision without abnormal findings
  • OR Z13.5 - Encounter for screening for eye disorders

Rationale:
Single elevated IOP reading insufficient for OHT diagnosis. Must confirm with repeated measurements using accurate technique (Goldmann applanation). Patient has normal IOP, does not have ocular hypertension. No H40.051 code warranted.

Example 7: Ocular Hypertension with Treatment Decision-Making

Clinical Scenario:
70-year-old patient with newly diagnosed ocular hypertension, discussing treatment options.

Risk Assessment:

  • IOP: 28 mmHg right eye
  • CCT: 545 microns (thin)
  • C/D: 0.55 (moderate)
  • Age: 70 (older)
  • Race: African American
  • Family history: Positive
  • OHTS risk calculator: ~20% 5-year glaucoma risk

Discussion with Patient:

  • High-risk features present
  • OHTS showed treatment reduces risk by 50%
  • Without treatment: 20% glaucoma risk over 5 years
  • With treatment: ~10% glaucoma risk over 5 years
  • Patient opts for treatment

ICD-10-CM Coding:

  • H40.051 - Ocular hypertension, right eye
  • H40.021 - Open angle with borderline findings, high risk, right eye (alternative if emphasizing high-risk status)
  • Z82.11 - Family history of glaucoma

Treatment Initiated:

  • Latanoprost (Xalatan) 0.005% nightly right eye
  • Target IOP reduction 20-30%
  • Follow-up in 4-6 weeks

Rationale:
H40.051 appropriate for OHT diagnosis. Additional risk factor codes (Z82.11) support clinical decision-making. High-risk profile justifies treatment per OHTS. Shared decision-making with patient important. Treatment is preventive, not curative.

Documentation Requirements

Essential Documentation for H40.051:

1. Elevated Intraocular Pressure Documented:
Must document:

  • IOP measurement: Specific number in mmHg
  • Method: Goldmann applanation tonometry (preferred), Tonopen, pneumatonometry, etc.
  • Right eye specified: “IOP right eye 26 mmHg”
  • Multiple measurements: At least 2-3 separate visits showing consistent elevation
  • Threshold: IOP >21 mmHg

Example: “Intraocular pressure by Goldmann applanation tonometry: Right eye 26 mmHg, left eye 18 mmHg. Confirmed on prior visit 2 weeks ago: Right eye 25 mmHg.”

2. Normal Optic Nerve Head - ESSENTIAL:
Must document that optic nerve is HEALTHY (no glaucomatous damage):

  • Cup-to-disc ratio (C/D): “Right eye C/D 0.4, healthy neuroretinal rim”
  • Neuroretinal rim: “Intact, pink, well-perfused”
  • ISNT rule: “Inferior rim thickest, superior, nasal, temporal”
  • No disc hemorrhages: “No Drance hemorrhages”
  • No RNFL defects: “No nerve fiber layer defects visible”
  • No notching, no pallor

Example: “Dilated fundus examination right eye reveals healthy optic nerve head with cup-to-disc ratio 0.4 vertically and 0.4 horizontally. Neuroretinal rim is intact, pink, and follows ISNT rule with no focal thinning or notching. No disc hemorrhages. No retinal nerve fiber layer defects appreciated. Optic nerve appearance normal.”

3. Normal Visual Field - ESSENTIAL:
Must document:

  • Visual field testing performed: Type (Humphrey, Octopus), protocol (24-2, 30-2)
  • Results NORMAL: “No glaucomatous defects”
  • Specific indices:
    • Mean deviation (MD): Within normal limits
    • Pattern standard deviation (PSD): Normal
    • Glaucoma Hemifield Test (GHT): Within normal limits

Example: “Humphrey visual field 24-2 SITA Standard right eye: Mean deviation -0.5 dB (within normal limits), PSD 1.8 dB (normal), GHT within normal limits. No glaucomatous visual field defects identified. Reliable test (fixation losses <20%, false positives <15%, false negatives <33%).”

4. Open Anterior Chamber Angle - ESSENTIAL:
Must document gonioscopy:

  • Gonioscopy performed
  • Angle OPEN: “Shaffer grade 3-4,” “360 degrees open”
  • Angle structures visible: “Trabecular meshwork, scleral spur, ciliary body band visible”
  • No peripheral anterior synechiae

Example: “Gonioscopy right eye: Angle open 360 degrees, Shaffer grade 3-4. Trabecular meshwork pigmented, scleral spur and ciliary body band visible. No peripheral anterior synechiae. No angle recession. Angle anatomy normal.”

5. Central Corneal Thickness (Pachymetry) - RECOMMENDED FOR RISK ASSESSMENT:
Document:

  • CCT measurement in microns
  • Right eye specified
  • Risk stratification significance:
    • Thin (<555 microns): Higher risk
    • Thick (>588 microns): Lower risk

Example: “Central corneal thickness by ultrasonic pachymetry: Right eye 545 microns, left eye 550 microns. Right eye CCT below 555-micron threshold indicates increased risk of glaucoma development per OHTS.”

6. Right Eye Specified:

  • Must clearly state “right eye” or “OD”
  • Laterality essential for coding H40.051
  • Document findings for each eye separately

7. Rule Out Secondary Causes:
Document:

  • Open angle (rules out angle-closure)
  • No evidence of pigment dispersion, pseudoexfoliation, uveitis, trauma (rules out secondary glaucoma)
  • Medication review: Note if on corticosteroids (steroid-induced glaucoma different code)

8. Risk Factor Assessment (Recommended):
Document risk factors for glaucoma conversion:

  • Age
  • Race/ethnicity (African American higher risk)
  • Family history of glaucoma
  • Baseline IOP level
  • Cup-to-disc ratio
  • Central corneal thickness
  • Calculated OHTS risk score (if available)

9. Assessment and Plan:

  • Diagnosis: “Ocular hypertension, right eye”
  • Risk level: “High-risk” or “Low-risk” for glaucoma development
  • Management plan:
    • Observation vs treatment (with rationale based on risk)
    • If treatment: Medication, target IOP
    • If observation: Monitoring frequency
  • Follow-up: Timing of next examination, repeat testing
  • Patient education: Glaucoma risk, warning signs, importance of follow-up

Complete Documentation Example (Supports H40.051):
“68-year-old African American female returns for glaucoma suspect evaluation. Patient was found to have elevated intraocular pressure on routine screening 2 months ago.

History: No eye symptoms. Mother had glaucoma. Medical history: Hypertension (controlled on lisinopril), no diabetes. No use of corticosteroids.

Examination: Best-corrected visual acuity 20/20 right eye, 20/20 left eye. Intraocular pressure by Goldmann applanation tonometry: Right eye 27 mmHg, left eye 18 mmHg. Consistent with prior visit IOP right eye 26 mmHg. Slit lamp examination: Anterior segments normal bilaterally, no cells/flare, no pigment dispersion, no pseudoexfoliative material.

Gonioscopy: Angle open 360 degrees bilaterally, Shaffer grade 3-4, all angle structures visible, no peripheral anterior synechiae.

Dilated fundus examination: Right eye optic nerve shows cup-to-disc ratio 0.5 vertically, 0.5 horizontally. Neuroretinal rim intact and healthy with appropriate ISNT configuration. No disc hemorrhages, no RNFL defects, no peripapillary atrophy. Left eye optic nerve cup-to-disc ratio 0.4, normal appearance.

Humphrey visual field 24-2 SITA Standard: Right eye mean deviation -0.8 dB (WNL), pattern standard deviation 1.9 dB (WNL), glaucoma hemifield test within normal limits. No glaucomatous defects. Left eye visual field normal.

OCT retinal nerve fiber layer: Right eye average thickness 95 microns (within normal limits), all quadrants green zone. Left eye 98 microns, normal.

Central corneal thickness by ultrasonic pachymetry: Right eye 538 microns, left eye 545 microns.

Assessment: Ocular hypertension, right eye. Patient has consistently elevated IOP right eye (26-27 mmHg) without evidence of glaucomatous optic neuropathy, retinal nerve fiber layer loss, or visual field defects. Anterior chamber angle open bilaterally on gonioscopy. Diagnosis confirmed as ocular hypertension right eye per established criteria.

Risk assessment: HIGH RISK for glaucoma development based on: elevated IOP (27 mmHg), thin central corneal thickness (538 microns, below 555-micron risk threshold), African American race, positive family history of glaucoma, age 68, and moderate cup-to-disc ratio (0.5). Estimated 5-year glaucoma risk approximately 20-25% based on OHTS risk calculator.

Plan: Given high-risk profile, recommend initiation of IOP-lowering therapy to reduce glaucoma risk. Discussed Ocular Hypertension Treatment Study findings showing 50% reduction in glaucoma development with treatment. Patient agrees to treatment. Prescribe latanoprost 0.005% one drop right eye nightly. Target IOP reduction 20-30% to <21 mmHg. Return in 4-6 weeks to assess IOP response to therapy. Will continue annual visual field and OCT monitoring to detect early conversion to glaucoma. Patient counseled on importance of medication adherence and regular follow-up.

ICD-10: H40.051, Z82.11, I10”

Insufficient Documentation Examples:

Example 1 - Insufficient:
“Patient has high eye pressure right eye.”

  • Missing: Specific IOP value
  • Missing: Evidence of multiple elevated measurements
  • Missing: Documentation of normal optic nerve
  • Missing: Documentation of normal visual fields
  • Missing: Gonioscopy findings
  • Cannot code H40.051 without comprehensive documentation

Example 2 - Insufficient:
“IOP 26 right eye, optic nerve normal.”

  • Missing: Confirmation on multiple visits
  • Missing: Visual field results
  • Missing: Gonioscopy (must confirm open angle)
  • Missing: Rule out secondary causes
  • Insufficient detail on optic nerve assessment
  • Need more complete documentation

Example 3 - Insufficient:
“Glaucoma suspect right eye.”

  • Too vague - what type of glaucoma suspect?
  • Could be H40.001 (preglaucoma unspecified) OR
  • Could be H40.011/021 (borderline findings) OR
  • Could be H40.051 (ocular hypertension)
  • Need specific diagnosis: elevated IOP vs suspicious nerve vs narrow angle

When to Query Physician:

Query for Confirmation of OHT Diagnosis:
“Patient has elevated IOP right eye (26 mmHg). Please confirm: Is optic nerve normal? Are visual fields normal? Is anterior chamber angle open on gonioscopy? Diagnosis: Ocular hypertension vs primary open-angle glaucoma?”

Query for Laterality:
“Documentation notes elevated IOP and ocular hypertension. Which eye is affected: right eye, left eye, or bilateral?”

Query for Completeness:
“For diagnosis of ocular hypertension, please document:

  • Normal optic nerve appearance (C/D ratio, rim assessment)
  • Normal visual field results
  • Gonioscopy confirming open angle
  • CCT measurement for risk assessment”

Query if Glaucoma Present:
“Patient has elevated IOP AND visual field defect right eye. Is diagnosis ocular hypertension (H40.051) or primary open-angle glaucoma (H40.111)?”

Billing and Coding Considerations

When to Use H40.051:

Appropriate Use:

  • Patient with consistently elevated IOP (>21 mmHg) right eye on multiple visits
  • Normal optic nerve, normal visual fields, open angle confirmed
  • No glaucomatous damage present
  • Glaucoma suspect based on IOP elevation
  • Both treated and untreated ocular hypertension

Medical Necessity:

H40.051 Supports:

  • Comprehensive ophthalmologic examinations with dilation
  • Gonioscopy to confirm open angle (essential for diagnosis)
  • Visual field testing (baseline and serial to detect conversion)
  • OCT imaging (RNFL and ganglion cell complex for baseline and monitoring)
  • Pachymetry (CCT for risk stratification - recommended by OHTS)
  • Optic nerve photography (documentation and monitoring)
  • Serial tonometry (multiple IOP measurements)
  • Frequent monitoring: Annual or more often if high risk
  • Treatment with IOP-lowering medications (if risk assessment indicates)

Monitoring Frequency:

  • Low-risk OHT: Annual comprehensive exams, visual fields, OCT
  • Moderate-risk: Every 6-12 months
  • High-risk: Every 4-6 months, or 3-4 months if on treatment
  • IOP checks: May be more frequent than comprehensive exams

Treatment Considerations:

Observation (Untreated):

  • Low-risk patients may be observed without treatment
  • OHTS: Some patients <5% 5-year risk
  • Close monitoring essential (annual VF, OCT)

Treatment (IOP-Lowering Medications):

  • High-risk patients benefit from treatment (OHTS: 50% risk reduction)
  • Shared decision-making with patient
  • Document rationale for treatment vs observation
  • Target IOP reduction: 20-30% from baseline, typically to <21 mmHg

Payer Considerations:

Medicare:

  • Covers medically necessary testing for glaucoma suspects
  • Gonioscopy covered (92020)
  • Visual fields covered annually (92083)
  • OCT covered annually for glaucoma suspects (92133)
  • Pachymetry (76514): Covered for glaucoma suspect evaluation (once for baseline, generally not annually unless clinical indication)
  • Comprehensive exams covered

Commercial Insurance:

  • Generally follows Medicare guidelines
  • Most cover appropriate testing for OHT
  • Prior authorization may be required for frequent testing
  • Medication coverage variable (formulary restrictions)

Coding with Treatment:

  • If patient on IOP-lowering medications, may add Z79.899 (long-term medication use)
  • Document medication names, frequency, compliance
  • Document IOP response to treatment

Common Billing Errors:

  1. Coding OHT when glaucoma present:
    • If optic nerve damage, RNFL loss, or VF defects present, NOT OHT
    • Must code as glaucoma (H40.11—)
    • Cannot code H40.051 once glaucoma develops
  2. Not documenting comprehensive evaluation:
    • Must document IOP, gonioscopy, optic nerve, visual fields
    • Without complete documentation, medical necessity questioned
  3. Single IOP measurement:
    • One elevated IOP insufficient for OHT diagnosis
    • Need 2-3 consistent measurements on separate visits
  4. Wrong laterality:
    • H40.051 (right) vs H40.052 (left) vs H40.053 (bilateral)
    • Code as documented
  5. Coding secondary glaucoma as OHT:
    • If steroid use, trauma, uveitis, etc., use secondary glaucoma codes (H40.3—, H40.4—, H40.6—)
    • Not H40.051
  6. Over-testing without medical necessity:
    • OCT, VF every 3-4 months without clinical indication may be questioned
    • Annual testing typically sufficient for stable OHT
    • More frequent if high risk or progression concern

Best Practices:

Documentation:

  • Complete baseline evaluation: IOP (multiple visits), gonioscopy, optic nerve, VF, OCT, pachymetry
  • Risk factor assessment and risk stratification
  • Rationale for treatment vs observation
  • Specific findings ruling out glaucoma
  • Right eye specified

Coding:

  • Use H40.051 for confirmed ocular hypertension right eye
  • Update to glaucoma code (H40.11—) if conversion occurs
  • Add Z-codes for family history (Z82.11), medication use (Z79.899)

Medical Necessity:

  • Justify testing frequency based on risk level
  • Document rationale for treatment decisions
  • OHTS data supports treatment for high-risk patients
  • Document patient education and shared decision-making

Quality Care:

  • Baseline comprehensive evaluation essential
  • Risk stratification using OHTS criteria
  • Appropriate monitoring frequency based on risk
  • Early detection of conversion to glaucoma
  • Patient education on glaucoma risk and importance of follow-up

This completes the comprehensive documentation for ICD-10-CM code H40.051.

Graph View

Recent Notes